These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 11148928

  • 1. [Hodgkin's disease with systemic vasculitis and Lambert-Eaton myasthenic syndrome--case report].
    Homenda W, Hellmann A.
    Wiad Lek; 2000; 53(9-10):574-8. PubMed ID: 11148928
    [Abstract] [Full Text] [Related]

  • 2. [Four cases of Hodgkin's disease treated with MOPP/ABV hybrid regimen using nitrogen mustard-N-oxide hydrochloride].
    Kozai Y, Ohyama T, Kodo H, Tomori G.
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2407-9. PubMed ID: 1281397
    [Abstract] [Full Text] [Related]

  • 3. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG, Broglia C, Levis A, La Sala A, Valentino F, Chisesi T, Sacchi S, Corbella F, Cavanna L, Iannitto E, Pavone V, Molica S, Corazza GR, Federico M.
    Clin Cancer Res; 2006 Jan 15; 12(2):529-35. PubMed ID: 16428496
    [Abstract] [Full Text] [Related]

  • 4. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Constine LS.
    J Clin Oncol; 1998 Mar 15; 16(3):1235. PubMed ID: 9508214
    [No Abstract] [Full Text] [Related]

  • 5. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.
    Chow LM, Nathan PC, Hodgson DC, Jenkin D, Weitzman S, Grant RM, Manson D, Bross A, Doyle JJ, Danjoux C, Greenberg ML.
    J Clin Oncol; 2006 Dec 20; 24(36):5735-41. PubMed ID: 17179107
    [Abstract] [Full Text] [Related]

  • 6. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
    Souza EM, Baiocchi OC, Zanichelli MA, Alves AC, Oliveira JS.
    Ann Hematol; 2009 Jul 20; 88(7):633-7. PubMed ID: 18998131
    [Abstract] [Full Text] [Related]

  • 7. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
    Noordijk EM, Carde P, Dupouy N, Hagenbeek A, Krol AD, Kluin-Nelemans JC, Tirelli U, Monconduit M, Thomas J, Eghbali H, Aleman BM, Bosq J, Vovk M, Verschueren TA, Pény AM, Girinsky T, Raemaekers JM, Henry-Amar M.
    J Clin Oncol; 2006 Jul 01; 24(19):3128-35. PubMed ID: 16754934
    [Abstract] [Full Text] [Related]

  • 8. Pediatric Hodgkin's disease.
    Oliapuram Jose B, Koerner P, Bertolone S, Patel CC, Spanos WJ, Paris KJ, Silverman CL, Yashar CM.
    J Ky Med Assoc; 2004 Mar 01; 102(3):104-6. PubMed ID: 15067795
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Simultaneously occurring alopecia areata and Hodgkin's lymphoma: complete remission of both diseases with MOPP/ABV chemotherapy.
    Chan PD, Berk MA, Kucuk O, Singh S.
    Med Pediatr Oncol; 1992 Mar 01; 20(4):345-8. PubMed ID: 1376855
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
    Aleman BM, Raemaekers JM, Tomiŝiĉ R, Baaijens MH, Bortolus R, Lybeert ML, van der Maazen RW, Girinsky T, Demeestere G, Lugtenburg P, Lievens Y, de Jong D, Pinna A, Henry-Amar M, European Organization for Research and Treatment of Cancer (EORTC) Lymphoma Group.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):19-30. PubMed ID: 17097834
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Relapse of Hodgkin disease after 17 years of complete remission. A case report].
    Osorio G, Caglevic C.
    Rev Med Chil; 2003 Feb 01; 131(2):197-9. PubMed ID: 12708259
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma.
    Hohaus S, Di Febo A, Storti S, Teofili L, Voso MT, Leone G.
    Haematologica; 2004 Jun 01; 89(6):751-2. PubMed ID: 15194545
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.